Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Crossref DOI link: https://doi.org/10.1007/s00277-017-3191-7
Published Online: 2017-12-27
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leleu, Xavier
Gay, Francesca
Flament, Anne
Allcott, Kim
Delforge, Michel
Funding for this research was provided by:
Amgen (Europe) GmbH
License valid from 2017-12-27